Foresee Pharmaceuticals Co., Ltd. (FP) is a clinical-stage pharmaceutical company. Our mission is to serve patients. We strive to improve patients’ quality of life and provide cure through innovative research. Foresee’s core competency includes rapid development and commercialization of new drugs using its proprietary drug delivery technology as well as develop first-in-class NCE in disease areas of high unmet medical needs. FP has two core technologies: Drug Delivery Technology： stabilized injectable formulation (SIF), a sustained-release drug delivery platform, and Rational Drug Design： novel new drug (New Chemical Entity, NCE) development. FP has also established long-term partnerships to provide the resources and flexibility required to rapidly advance an asset from research to development and eventually to commercialization.